Table 4.

Molecular Status of Stage III Tumors

Stage III Characteristic	No. of Patients	1p+/16q+		1p+/16q−		1p−/16q+		1p−/16q−
		No.	%	No.	%	No.	%	No.	%
Gross residual disease	43	0	0	1	2	7	16	35	81
LN positivity	299	18	6	27	9	37	12	217	73
Microscopic residual disease	228	7	3	18	8	32	14	171	75
Diffuse spill	107	2	2	4	4	20	19	81	76
Peritoneal implants	21	1	5	0	0	3	14	17	81

Abbreviation: LN, lymph node.